In the brain of stroke patients, the expression of TSG-6 is elevated in the peri-infarct and infarcted tissue areas [69], whereas, in non-cardioembolic acute ischemic stroke patients, the increase in plasma levels of TSG-6 was positively associated with disease severity and lesion volume [70]. This evidence concerns the gene TNFAIP6 and stroke disorder.